These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35240444)

  • 1. Propranolol inhibits cell viability and expression of the pro-tumorigenic proteins Akt, NF-ĸB, and VEGF in oral squamous cell carcinoma.
    Shibuya CM; Tjioe KC; Oliveira SHP; Bernabé DG
    Arch Oral Biol; 2022 Apr; 136():105383. PubMed ID: 35240444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of IGF-1 on Proliferation, Angiogenesis, Tumor Stem Cell Populations and Activation of AKT and Hedgehog Pathways in Oral Squamous Cell Carcinoma.
    Ferreira Mendes JM; de Faro Valverde L; Torres Andion Vidal M; Paredes BD; Coelho P; Allahdadi KJ; Coletta RD; Souza BSF; Rocha CAG
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HOXA1 silencing inhibits cisplatin resistance of oral squamous cell carcinoma cells via IκB/NF-κB signaling pathway.
    Zhu R; Mao Y; Xu X; Li Y; Zheng J
    Anticancer Drugs; 2024 Jul; 35(6):492-500. PubMed ID: 38477942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo synergistic anti-tumor effect of LIN28 inhibitor and metformin in oral squamous cell carcinoma.
    Chen H; Sa G; Li L; He S; Wu T
    Eur J Pharmacol; 2021 Jan; 891():173757. PubMed ID: 33249080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-phenylethynesulfonamide inhibits growth of oral squamous cell carcinoma cells by blocking the function of heat shock protein 70.
    Jiang L; Xiao J
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32110810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a Novel Oral Chemotherapeutic Agent, TAS-102, Against Human Oral Squamous Cell Carcinoma Cells.
    Harada K; Ferdous T; Mishima K
    Anticancer Res; 2021 Dec; 41(12):6039-6049. PubMed ID: 34848458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-1 inhibits tumorigenicity and angiogenesis of human oral squamous cell carcinoma cells by suppressing expression of phosphorylated Akt, vascular endothelial growth factor and fibroblast growth factor-2.
    Harada K; Supriatno ; Kawashima Y; Yoshida H; Sato M
    Int J Oncol; 2007 Feb; 30(2):365-74. PubMed ID: 17203218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting the PI3K/Akt, NF-κB signalling pathways with syringic acid for attenuating the development of oral squamous cell carcinoma cells SCC131.
    Velu P; Vijayalakshmi A; Vinothkumar V
    J Pharm Pharmacol; 2020 Nov; 72(11):1595-1606. PubMed ID: 32790092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells.
    Hong KO; Kim JH; Hong JS; Yoon HJ; Lee JI; Hong SP; Hong SD
    J Exp Clin Cancer Res; 2009 Feb; 28(1):28. PubMed ID: 19243631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Akt Signal Transduction Pathways and Nuclear Factor-kappa B (NF-κB) Transcription as a Molecular Target of Oral Tongue Squamous Cell Carcinoma (SP-C1) Using Papua's Anthill Plant ( Myrmecodia pendans ).
    Achmad H; Supriatno ; Singgih MF; Hendrastuti H
    Pak J Biol Sci; 2016; 19(8-9):323-330. PubMed ID: 29023018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted disruption of PI3K/Akt/mTOR signaling pathway, via PI3K inhibitors, promotes growth inhibitory effects in oral cancer cells.
    Aggarwal S; John S; Sapra L; Sharma SC; Das SN
    Cancer Chemother Pharmacol; 2019 Mar; 83(3):451-461. PubMed ID: 30519710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF-C expression in oral cancer by neurotransmitter-induced activation of beta-adrenergic receptors.
    Vilardi BM; Bravo-Calderón DM; Bernabé DG; Oliveira SH; Oliveira DT
    Tumour Biol; 2013 Feb; 34(1):139-43. PubMed ID: 23065569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-Hydroxybutenolide impairs cell migration, and invasion of human oral cancer SCC-4 cells via the inhibition of NF-κB and MAPK signaling pathways.
    Yu FS; Lin ML; Hsu SC; Yu CC; Huang YP; Kuo YH; Chung JG
    Int J Oncol; 2016 Aug; 49(2):579-88. PubMed ID: 27221634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the response of normal oral mucosa, oral leukoplakia, oral squamous cell carcinoma-derived mesenchymal stem cells, and epithelial cells to photodynamic therapy.
    Guo Q; Ji X; Zhang L; Liu X; Wang Y; Liu Z; Jin J; Han Y; Liu H
    J Photochem Photobiol B; 2024 Jun; 255():112907. PubMed ID: 38677259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of ROS/NUPR1-dependent autophagy antagonises repeated cadmium exposure -induced oral squamous cell carcinoma cell migration and invasion.
    Fan T; Chen Y; He Z; Wang Q; Yang X; Ren Z; Zhang S
    Toxicol Lett; 2019 Oct; 314():142-152. PubMed ID: 31319114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Maackia amurensis seed lectin (MASL) on oral squamous cell carcinoma (OSCC) gene expression and transcriptional signaling pathways.
    Hamilton KL; Sheehan SA; Retzbach EP; Timmerman CA; Gianneschi GB; Tempera PJ; Balachandran P; Goldberg GS
    J Cancer Res Clin Oncol; 2021 Feb; 147(2):445-457. PubMed ID: 33205348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Operculina turpethum extract inhibits growth and proliferation by inhibiting NF-κB, COX-2 and cyclin D1 and induces apoptosis by up regulating P53 in oral cancer cells.
    Arora R; Bharti V; Gaur P; Aggarwal S; Mittal M; Das SN
    Arch Oral Biol; 2017 Aug; 80():1-9. PubMed ID: 28351666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA‑149‑3p inhibits cell proliferation by targeting AKT2 in oral squamous cell carcinoma.
    Shen Q; Zhu H; Lei Q; Chen L; Yang D; Sui W
    Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33398370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced lipid biosynthesis in oral squamous cell carcinoma cancer-associated fibroblasts contributes to tumor progression: Role of IL8/AKT/p-ACLY axis.
    Liu P; Wang Y; Li X; Liu Z; Sun Y; Liu H; Shao Z; Jiang E; Zhou X; Shang Z
    Cancer Sci; 2024 May; 115(5):1433-1445. PubMed ID: 38494608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.